THE term`unclassi®able or undierentiated spondyloarthropathy' (USpa) refers to a group of patients with in¯ammatory backache, oligoarticular asymmetrical arthritis, enthesitis with or without radiological evidence of sacroiliitis, but not ful®lling the diagnostic criteria for any of the currently established diseases such as ankylosing spondylitis, psoriatic arthritis, reactive arthritis or arthritis associated with chronic in¯ammatory bowel disease [1, 2] . In this context,`undierentiated' might mean an early stage of a de®nite spondyloarthropathy (Spa), a forme fruste of a de®nite Spa, an aetiologically as yet unde®ned subcategory of Spa [1] .
Reactive arthritis is a form of Spa in which there is evidence of preceding genitourinary or enteric infection. These patients show heightened immune response to the triggering agent, as evidenced by an increase in IgG/IgA antibody level in sera [3, 4] and enhanced antigen-speci®c proliferation of synovial uid lymphocytes [5] . In addition, bacterial components have been found in the synovial cells/tissue of these patients [6, 7] . Because of similarities in the clinical pictures of reactive arthritis and USpa, it is possible that the latter disease entity represents an incomplete form of the former in which the inciting infection is asymptomatic or clinically inapparent. In fact, in a recent study, 5/7 patients with USpa were shown to have IgG antibodies against Chlamydia trachomatis [4] . As the triggering organism depends on the nature of infection in a community, we decided to look for evidence of an antibody response against implicated infectious agents in patients with USpa.
PATIENTS AND METHODS
Patients with spondyloarthropathy as de®ned by 1991 European Spondyloarthropathy Study Group criteria [8] were included in the study. Patients with ankylosing spondylitis, in¯ammatory bowel disease, psoriasis and with a history of preceding infection were excluded. Sera were collected during the active phase and stored at ±808C until analysis. Fifty-one healthy blood donors served as controls.
Antigen preparation
Yersinia enterocolitica O:3 strain, Campylobacter jejuni, Salmonella typhimurium (ATCC-13311), Shigella¯exneri 2b (kind gift from P. Toivanen, Turku, Finland) and Escherichia coli (NCTC-10418) were grown overnight in nutrient broth at 378C. The following morning, bacteria were pelleted and washed three times with phosphate-buered saline (0.15 M, pH 7.2). The bacteria were lysed using a pulse sonicator. After centrifugation at 12 000 g for 30 min at 48C, supernatant was collected, aliquoted and stored at ±808C.
ELISA for IgA antibacterial antibodies
Ninety-six-well ELISA plates (Nunc, Germany) were coated with 50 ml of the respective antigen (10 mg/ml) in carbonate±bicarbonate buer (pH 9.6) and incubated at 48C overnight. After blocking with 2% bovine serum albumin (BSA) for 2 h, diluted serum (1:100) was added and incubated for 2 h at 378C. Following washing with phosphate-buered saline (pH 7.2, 0.15 M) containing 0.05% Tween 20 (PBS-T), 50 ml of anti-human IgA conjugated with horseradish peroxidase (Dakopatts, Denmark, 1:5000) were added to each well and kept at 378C for 1 h. Plates were washed three times with PBS-T. Colour was developed by addition of 50 ml of substrate solution [citrate phosphate buer (pH 5.0) containing ophenyldiamine (0.4 mg/ml) and 0.04% hydrogen peroxide]. The reaction was stopped by 2.5 N sulphuric acid and plates were read at 492 nm in an ELISA reader. OD values exceeding the mean + 2 S.D. of healthy controls were taken as positive.
ELISA for IgA anti-chlamydia antibodies
The ELISA was performed using a commercial kit (Eurogenetics, Belgium) according to the manufacturer's instructions. The samples with an absorbance value 15% higher than the mean absorbance of the cut-o control serum (provided in the kit) were classi®ed as positive. Eighteen control sera from blood bank donors were also tested. The antigen coated is cellular extract from the LV2 strain and it predominantly detects antibodies to C. trachomatis.
Statistical analysis
The w 2 test was used for inter-group comparisons. RESULTS There were 14 patients with USpa and four of these were females. The median age at presentation was 27 yr (16±45 yr) and the median duration of disease was 2.5 yr (0.6±15 yr). The main features were enthesitis and sacroiliitis along with in¯ammatory low backache and asymmetrical oligoarthritis (Table I) . HLA B27 was present in three of the six patients tested.
The Chlamydia was found to be 0.51 and none of 18 normals were above this value. Five patients had elevated IgA antibodies to Shigella, while two each had elevated IgA levels to Chlamydia and Salmonella (Table II) . No cross-reactivity was observed between dierent bacteria. The dierence in the prevalence of antibodies to Shigella (P < 0.0005) and Chlamydia (P < 0.05) was signi®c-antly higher in the patient group, while there was no signi®cant dierence in the prevalence of antibodies to Salmonella.
DISCUSSION
We observed that nine of these 14 patients with USpa had a heightened serum IgA response to a single organism implicated in the pathogenesis of reactive arthritis, suggesting that 64% of patients might have an inapparent infection.
The presence of an IgA antibody response to a single bacterium and not to the whole panel of Enterobacteriaceae implies that the response is not directed against cross-reactive epitopes, but to species-speci®c antigens. Some of our patients, surprisingly, had an elevated IgA response even after several years of disease. In reactive arthritis, an IgA response may persist for years [3] and is most likely due to persistence of antigen either in the gut or synovium [9] .
Most studies from the developed countries found direct or indirect evidence of Chlamydia infection in their group of patients with undierentiated oligoarthritis [7, 10] . Among the enteric organisms, Yersiniatriggered arthritis accounts for most cases of sporadic enteric reactive arthritis [11] . On the other hand, our data suggest that Shigella and Salmonella are a quite common triggering factor, re¯ecting a higher incidence of gastrointestinal infections as well as the bacteriology of diarrhoea [12] .
Shigella is the commonest cause of diarrhoea in North India, as re¯ected in a study from our centre [13] . It is generally believed that inapparent infection with Shigella is uncommon and this bacterium does not persist in the body. Contrary to this belief, inapparent infection was quite common in an outbreak of S.¯exneri [14] . This, in turn, may lead to spondyloarthropathy in a susceptible host. In addition, a long-term Shigella carrier state is also known [15] and bacterial lipopolysaccharides have been found in synovial cells of patients with reactive arthritis [6] . Further, Shigella-induced reactive arthritis can have a chronic course which may simulate USpa if the infection was asymptomatic.
Involvement of Chlamydia as the triggering factor in two patients supports the observation of others [7, 10, 11] . Chlamydia was found to be the most important inciting agent in patients with asymmetrical oligoarthritis without any preceding history of infection [10] . Further IgA antibodies to Chlamydia were indicative of infection. A lack of antibodies to enteric organisms in their study may be due to dierences in the prevalence of these infections in their community [10] .
Thus, our study suggests that H64% of patients with USpa may indeed be cases of reactive arthritis where either the infection was asymptomatic or was too trivial to be remembered by the patient. Our data have to be viewed in light of the fact that a humoral response is still indirect evidence for a cause and eect relationship. The diagnosis of enteric infection based on serology has its own limitations. Therefore, further studies on synovial¯uid lymphocytes, such as antigen-induced proliferation or cloning of antigenspeci®c T cells from this group of patients, along with a search for antigen or bacterial DNA and RNA in the synovium, may provide the ®nal proof.
